Typhim VI 25 MCG/0.5 ML vial 10ML

Ended Awarded

Contract number
SPE2DX24FMLMK
Awardee
Awarding agency
Obligated
$1,040

Award facts

Contract value 100% obligated
$1,040.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $1,040.42 contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, to provide a comprehensive range of pharmaceutical items to the Department of Defense. This award does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DX24FMLMK?

SPE2DX24FMLMK was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 23, 2024.

How much is contract SPE2DX24FMLMK worth?

The government has obligated $1,040 on SPE2DX24FMLMK.

Is contract SPE2DX24FMLMK an order under another contract?

Yes. SPE2DX24FMLMK is a delivery order under SPE2DX15D9336, an indefinite delivery contract.

Was contract SPE2DX24FMLMK competed?

The extent of competition for SPE2DX24FMLMK was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award